Drugs / DA-3803
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01851512 | May → Aug 2010 | infertility disorder | Dong-A Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-3803 | “DA-3803 Injection is injected first and Ovidrel liquid injection is injected after 3-week period” NCT01851512 ↗ |
| Known as | Drug: DA-3803 (Test drug) | “Drug: DA-3803 (Test drug)” NCT01851512 ↗ |
| Modality | Protein / enzyme biologic | “two recombinant hCG products named DA-3803 injection and ovidrel liquid injection” NCT01851512 ↗ |